Hyman Phelps and McNamara
 
Firm Publications
 

The Problem of the ‘Intended Use’ Regulations Continues to Fester
March 21, 2017

In 2015, FDA proposed revising the so-called intended use regulation (21 CFR 201.128; id. § 801.4)to remove the famous “knowledge” sentence: “But if a manufacturer knows, or has knowledge of facts that would give him notice, that a [drug or device] introduced into interstate commerce … is to be used for conditions, purposes, or uses other than the ones for which he offers it, he is required to provide adequate labeling for such a drug/device which accords with such other uses to which the article is to be put.”

In the proposed rule, FDA indicated that removing the sentence was nothing more than a clarification “to better reflect FDA’s interpretation and application of these regulations.” At the time, we blogged very favorably on this change, describing it as long overdue.

Click here to view the PDF

If you have any questions regarding the above information, please contact:
Jeffrey K. Shapiro (202) 737-9633 jshapiro@hpm.com